R&D | April 15, 2026
Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India
A major push to sharpen the future of cancer treatment is underway
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Green Vision Centres cut emissions, expand community coverage as partners align on resilient eye health systems
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The company says the platform offers improved manufacturability and functional advantages
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Subscribe To Our Newsletter & Stay Updated
